The Advanced Research Projects Agency for Health (ARPA-H) announced the launch of two new programs (here and here) to advance the development and manufacturing of cell and gene medicines. Additionally, the Food and Drug Administration (FDA) issued draft guidance on innovative clinical trial designs for cell and gene therapies in small populations. Additional information on each development follows. The Treating… (Slifer, September 25, 2025) #Food and Drug Administration, #Prescription Drugs